Team: Bios

Frank Baldino Jr., PhD Venture Partner

The founder of Cephalon in 1987 and currently the Chairman of Cephalon's Board and Chief Executive Officer, Dr. Baldino has nearly two decades of scientific experience in neurobiology, molecular biology and electrophysiology, and has authored more than 100 publications in peer-reviewed journals such as Nature, Journal of Neuroscience Research and Brain Research. From 1981-1987, Dr. Baldino served as senior research biologist in the medical products department at E.I. DuPont de Nemours & Company, where he was responsible for developing research strategies for identifying novel neuropharmaceutical agents. Dr. Baldino serves as Chairman of the Board of the BioAdvance Biotechnology Greenhouse Corp., is a member of the Executive Council of the Harvard Division of Sleep Medicine, and is a member of the Board of Trustees at Temple University and The Franklin Institute. In addition, Dr. Baldino serves as a member of the Board of Directors for the Greater Philadelphia Chamber of Commerce, the Eastern Technology Council, Biotechnology Industry Association (BIO), Inc. and holds several adjunct academic appointments. Dr. Baldino received his Ph.D. in pharmacology from Temple University.

Present Boards
Acusphere, Inc. (NASDAQ:ACUS)
Cephalon, Inc. (NASDAQ:CEPH)
NicOx, S.A. (Euronet Paris:COX)
Pharmacopeia, Inc. (NASDAQ:PCOP)
Quaker BioVentures, L.P.

Past Board
ViroPharma, Inc. (NASDAQ:VPHM)